Intapp
INTA
37.60
+0.57
+1.54%
Intapp
US · INTA
#2546 by market cap
Listed 2021
37.60
+0.57
+1.54%
Live - 5344 symbols - heartbeat 82s ago
· 2026-10-08 04:42
Pre-market
37.54
-0.15%
After-hours
37.60
0.00%
Overnight
37.60
0.00%
- Market cap
- 2.88B
- P/E (TTM)i
- -72.31
- P/Bi
- 9.08
- EPSi
- -0.52
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on INTA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.88, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.62% YoY
Margins
- Gross margin
- 75.78%
- Operating margin
- -6.94%
- Net margin
- -7.15%
Key ratios & quality
- Altman Z-Scorei
- 2.88
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 143.22M | 186.85M | 214.63M | 272.07M | 350.87M | 430.52M | 504.12M | 577.81M |
| Gross profit | 98.33M | 115.56M | 140.26M | 172.99M | 239.41M | 306.86M | 372.97M | 437.85M |
| Selling & admin expenses | 73.61M | 87.39M | 112.37M | 198.03M | 213.22M | 225.42M | 262.57M | 310.63M |
| Research & development | 28.83M | 42.09M | 50.85M | 74.41M | 93.85M | 113.63M | 137.76M | 167.32M |
| Operating profit | -4.10M | -13.92M | -22.96M | -99.46M | -67.66M | -32.19M | -27.36M | -40.10M |
| Pretax profit | -24.95M | -45.56M | -46.29M | -103.11M | -69.92M | -29.91M | -16.14M | -37.24M |
| Tax | -7.81M | 353.00K | 472.00K | -3.44M | -495.00K | 2.12M | 2.08M | 4.07M |
| Net profit | -17.14M | -45.92M | -46.76M | -99.68M | -69.43M | -32.02M | -18.22M | -41.31M |
| Basic EPS | -1 | -2 | -2 | -2 | -1 | 0 | 0 | -1 |
| Diluted EPS | -1.04 | -2.15 | -2.23 | -1.63 | -1.08 | -0.45 | -0.23 | -0.52 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 129.07M | 135.04M | 139.03M | 140.21M | 146.04M | 152.53M |
| Gross profit | 96.41M | 100.96M | 103.83M | 105.14M | 110.51M | 118.37M |
| Selling & admin expenses | 68.02M | 67.25M | 77.35M | 73.03M | 80.61M | 79.64M |
| Research & development | 34.09M | 37.92M | 40.93M | 39.28M | 44.14M | 42.95M |
| Operating profit | -5.70M | -4.22M | -14.46M | -7.18M | -14.25M | -4.22M |
| Pretax profit | -2.32M | 400.00K | -13.40M | -5.26M | -14.41M | -4.17M |
| Tax | 634.00K | 928.00K | 957.00K | 672.00K | 1.08M | 1.36M |
| Net profit | -2.95M | -528.00K | -14.35M | -5.93M | -15.50M | -5.53M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.04 | -0.01 | -0.18 | -0.07 | -0.20 | -0.07 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 67.50M | 84.40M | 113.88M | 147.39M | 254.84M | 342.65M | 455.88M | 315.18M |
| Cash & ST investments | 21.50M | 42.05M | 37.64M | 50.78M | 130.38M | 208.37M | 313.11M | 162.81M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 366.24M | 377.01M | 459.83M | 494.41M | 628.91M | 733.00M | 894.16M | 753.66M |
| Total current liabilities | 92.39M | 116.81M | 171.88M | 223.52M | 259.35M | 300.65M | 349.86M | 405.84M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 268.32M | 279.46M | 275.59M | -- | -- | -- | -- | -- |
| Total liabilities | 365,191,000.00 | 403,528,000.00 | 473,259,000.00 | 238,531,000.00 | 287,699,000.00 | 329,761,000.00 | 374,396,000.00 | 436,055,000.00 |
| Total equity | 1.05M | -26.52M | -13.43M | 255.88M | 341.21M | 403.24M | 519.77M | 317.60M |
| Retained earnings | -189.92M | -238.20M | -286.06M | -385.74M | -455.16M | -487.18M | -505.40M | -823.59M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 432.98M | 455.88M | 384.28M | 359.40M | 275.74M | 315.18M |
| Cash & ST investments | 323.21M | 313.11M | 273.44M | 191.15M | 146.82M | 162.81M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 813.51M | 894.16M | 823.26M | 795.18M | 709.14M | 753.66M |
| Total current liabilities | 297.32M | 349.86M | 311.47M | 358.72M | 360.54M | 405.84M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 321,205,000.00 | 374,396,000.00 | 336,900,000.00 | 384,929,000.00 | 388,939,000.00 | 436,055,000.00 |
| Total equity | 492.30M | 519.77M | 486.36M | 410.25M | 320.20M | 317.60M |
| Retained earnings | -504.87M | -505.40M | -569.77M | -675.75M | -792.24M | -823.59M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -5.06M | -1.41M | -9.75M | 14.24M | 27.49M | 67.23M | 123.53M | 146.85M |
| Depreciation & amortization | 9.05M | 12.77M | 13.37M | 16.74M | 19.96M | 21.49M | 22.71M | 23.95M |
| Free cash flow | -9.36M | -6.54M | -14.75M | 9.45M | 19.75M | 58.38M | 114.49M | 136.36M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 3.00M | -2.77M | 27.13M | 292.76M | 70.08M | 0 | 0 | -275.17M |
| Ending cash balance | 22.62M | 43.16M | 41.46M | 54.31M | 131.19M | 208.57M | 313.31M | 163.01M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 35.50M | 38.34M | 13.80M | 22.88M | 63.92M | 46.26M |
| Depreciation & amortization | 5.38M | 5.93M | 6.00M | 6.17M | 6.36M | 5.42M |
| Free cash flow | 33.08M | 35.59M | 10.94M | 20.10M | 61.30M | 44.02M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -50.02M | -100.05M | -100.08M | -25.02M |
| Ending cash balance | 323.41M | 313.31M | 273.64M | 191.35M | 147.02M | 163.01M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -202.80 | -23.25 | -8.60 | -3.95 | -9.87 |
| ROA %i | -7.97 | -16.14 | -14.90 | -20.89 | -12.36 | -4.70 | -2.24 | -5.01 |
| ROIC %i | -- | -- | -- | -202.26 | -22.01 | -8.21 | -3.80 | -9.90 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -49.69 |
| EBIT margin %i | -3.49 | -9.48 | -10.10 | -37.80 | -19.88 | -7.48 | -5.43 | -6.94 |
| FCF / sales %i | -- | -- | -- | 3.47 | 5.63 | 13.56 | 22.71 | 23.60 |
| Current ratioi | 0.73 | 0.72 | 0.66 | 0.66 | 0.98 | 1.14 | 1.30 | 0.78 |
| Quick ratioi | 0.64 | 0.64 | 0.55 | 0.57 | 0.91 | 1.06 | 1.22 | 0.69 |
| Debt / assetsi | 73.26 | 74.12 | 59.93 | 0.00 | 2.58 | 2.67 | 1.80 | 2.10 |
| LT debt / equityi | -- | -- | -- | -- | 4.75 | 4.86 | 3.10 | 4.99 |
| Interest coveragei | -0.25 | -0.64 | -0.88 | -375.32 | -447.21 | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 23.85 | 23.37 | 26.12 | 22.82 | 18.09 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 129.68 | 90.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -4.16 | -3.95 | -6.04 | -5.41 | -8.94 | -9.87 |
| ROA %i | -2.44 | -2.24 | -3.58 | -2.98 | -4.77 | -5.01 |
| ROIC %i | -4.00 | -3.80 | -5.82 | -5.22 | -8.61 | -9.90 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -4.72 | -5.43 | -6.59 | -5.81 | -7.16 | -6.94 |
| FCF / sales %i | 21.53 | 22.71 | 19.62 | 18.35 | 22.83 | 23.60 |
| Current ratioi | 1.46 | 1.30 | 1.23 | 1.00 | 0.76 | 0.78 |
| Quick ratioi | 1.37 | 1.22 | 1.15 | 0.92 | 0.68 | 0.69 |
| Debt / assetsi | 2.04 | 1.80 | 1.96 | 1.87 | 1.96 | 2.10 |
| LT debt / equityi | 3.38 | 3.10 | 3.31 | 3.62 | 4.35 | 4.99 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United States (US)67.80%
United Kingdom (UK)16.27%
Rest of the world15.93%
Quote time 2026-10-08 04:42:19 · For reference only, not investment advice and not tailored to your situation.